SecBot SecBot

CODX

Co-Diagnostics, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. UT· CIK 0001692415 Healthcare & Medical Devices
$0.4689 −0.08 (−14.28%)
Oct 27 4:00 PM ET · prev $0.5470
Market cap
$4.4M
Nano cap
Median target
$4.00
+753% · range $4.00–4.00
Next earnings
Nov 11
in 15 days · EPS est. −$1.25
1 year
−97.3%
from $17.10 · Oct 28
30 days
−57.8%
from $1.11
52-week range
$0.4689–17.10
at the low
Avg volume 20D
453.7K
Oct 27 spike 1.22M
Short interest
🔒 Subscribers only
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 1 mention this week
Filing reports
15
analyzed by SecBot
SecBot read BEARISH 8 reports · 90 days
Balance 5 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 6/8 ·Next Earnings date, Nov 11, 2026
Strongest BEARISH Co-Diagnostics is holding a court-ordered special meeting on November 13, 2026 to vote on nine proposals…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 1 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$2.850 → −$1.250 over 90 days. 1 up, 0 down in 30 days.

  • TrendDOWNTREND

    54% below its 50-day average. New closing low $0.4689 on Oct 27.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup call.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD FIDUCIARY TRUST CODOUBLED19,776$61.3K
UBS Group AGDOUBLED16,091$49.9K
MORGAN STANLEYDOUBLED2,877$8.9K
JPMORGAN CHASE & CONEAR_EXIT3$9.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Nov 2025
12-month targets · 1 analysts

Price is below the lowest target. Median implies +753%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Nov 26, 2025Maxim Group
INITIATE
INITIATEBuy
Nov 24, 2025HC Wainwright & Co.
REITERATE
REITERATENeutral
Oct 28, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Oct 16, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Sep 19, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Sep 17, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 0 in posts · 1 in comments
Recent comments
r/pennystocks Neutral 2d ago
I'm curious to know your thoughts on CODX. They previously benefitted from the pandemic, possible went public too soon and the stock suffered. Now they've got there product back in FDA review and might turn the corner.
All social signals and their track records

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
May 23, 2026
Brown Brian Lee
Chief Financial Officer
AWARD3,750 sh
May 23, 2026
Abbott Richard David
President
AWARD1,890 sh
May 23, 2026
Brown Brian Lee
Chief Financial Officer
TO ISSUER$6.8K
May 23, 2026
Brown Brian Lee
Chief Financial Officer
EXERCISE3,750 sh
May 23, 2026
SERBIN RICHARD S
Director
EXERCISE1,695 sh
May 23, 2026
Abbott Richard David
President
TO ISSUER$3.4K
May 23, 2026
Murphy Edward L.
Director
AWARD1,695 sh
May 23, 2026
SERBIN RICHARD S
Director
AWARD1,695 sh

Earnings setup

Estimates
Nov 11
reports in 15 days
−$1.25
EPS estimate, this quarter
+56%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$1.25-$1.25–-$1.25+62.1%$169.0K
Next Q-$0.27-$0.27–-$0.27+91.8%$173.0K
Current FY-$3.10-$3.10–-$3.10+77.0%$654.0K
Next FY-$0.83-$0.83–-$0.83+93.1%$17.3M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
Co-Diagnostics is holding a court-ordered special meeting on November 13, 2026 to vote on nine proposals, including…
DEF 14A — Impact 6/10
Oct 15, 2026 SEC
Co-Diagnostics filed an 8-K/A to correct the original 8-K by removing Maxim Group LLC as a party to the ATM Waterfall…
8-K/A — Impact 6/10
Oct 13, 2026 SEC
Co-Diagnostics entered into a $3.1M senior secured loan facility with J.J. Astor & Co., structured as a high-cost debt…
8-K — Impact 7/10
Sep 15, 2026 Routine
Co-Diagnostics to Hold Press Conference
Media, analysts and investors are welcome to attend in person or via live webcast, Sept. 16 at 10:30
Jun 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO — DOUBLED
19,776 shares ($61.3K)
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
16,091 shares ($49.9K)
May 23, 2026 Insider
Brown Brian Lee was granted 3,750 shares
Chief Financial Officer
May 23, 2026 Insider
Abbott Richard David was granted 1,890 shares
President
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
CODX Q3 2026 Earnings Scheduled — 2026-11-11
Recent
Sep 15, 2026
Company news
Co-Diagnostics to Hold Press Conference
Media, analysts and investors are welcome to attend in person or via live webcast, Sept. 16 at 10:30 a.m. ET SALT LAKE CITY, Sept. 15, 2026…
Aug 12, 2026
Earnings date
CODX Q2 2026 Earnings Scheduled — 2026-08-12
May 14, 2026
Earnings date
CODX Q1 2026 Earnings Scheduled — 2026-05-14
May 6, 2026
Earnings date
CODX Q1 2026 Earnings Scheduled — 2026-05-06
Mar 23, 2026
Short interest
FTD: CODX — 332,408 shares ($0.9M) failed to deliver
Settlement: 20260323, Price: $2.59, FTD Value: $860,936.72, CO-DIAGNOSTICS INC COM NEW

SecBot reports

15 filings · 0 bullish · 12 bearish · 3 neutral
All CODX filing & press-release reports (15)